ACTIVE

LEGACY

Export PDF
Financial year 2024 · closed on 31/12/2024
Net result
22,5 k €
+1314.2% YoY
Gross margin
51,8 k €
+140.7% YoY
Equity
104 €
+100.5% YoY
Workforce
0,0 ETP

What does LEGACY do?

LEGACY is a Private limited company incorporated in 2015. Its registered office is in Oudenaarde.

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0644.482.945
Incorporation
14/12/2015
Legal form
Private limited company
Registered office
Reytstraat 103
9700 Oudenaarde · FlandreSee on map
Contributed capital
6 200,00 €
Latest accounts
31/12/2024
Average workforce
0,0 ETP
Signals
ProfitablePositive cashflowPositive EBITDA
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 8 financial years

20242023202220212019201820172016
Income statement
Gross margin51,8 k €21,5 k €-5,8 k €-5,8 k €6 k €5,1 k €-5,2 k €-2,9 k €
EBITDA47,7 k €19,1 k €-7,4 k €-7,1 k €5,3 k €4,2 k €-14,3 k €-3 k €
Operating result46,7 k €19,1 k €-7,4 k €-8,1 k €4,1 k €3,3 k €-14,3 k €-3 k €
Net result22,5 k €1,6 k €-8 k €-9,2 k €831,5 €3,2 k €-14,3 k €-3,1 k €
Balance sheet
Equity104 €-22,4 k €-24 k €-16,1 k €-7,2 k €-8 k €-11,2 k €3,1 k €
Total assets110,8 k €83,2 k €21,4 k €15,4 k €61,1 k €14,4 k €3 k €3,3 k €
Cash20,9 k €5,7 k €3,1 k €4,3 k €2,3 k €–95,7 €–
Debts110,1 k €105,5 k €45,4 k €31,4 k €68,3 k €22,4 k €14,3 k €169,6 €
Other
Workforce0,0 ETP0,0 ETP––––0,3 ETP–
Estimate

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2024 · 2 active · 8 ended

Active mandates

TRAVEL PHARMA

Director · since 31 janvier 2025 · 0644.400.989

Represented by Schmitt ALEXANDER

Active
Marieke Boullart

Director · since 12 décembre 2015

Active

Ended mandates

Alexander Schmitt

Director · since 01 juillet 2018

Ended
Alexander SCHMITT

Manager · since 01 juillet 2018

Ended
Marieke BOULLART

Manager · since 12 décembre 2015

Ended
AUTHORITY

Manager · since 11 décembre 2015 · 0846.644.605

Represented by Alexander SCHIMITT

Ended
At this address

Other companies at this address

CompanyCBE no.
AUTHORITY● Active
0846.644.605
TRAVEL PHARMA● Active
0644.400.989
Annual accounts

Full financial information

202420232022202120202019
Type of accountAbridged modelAbridged modelMicro modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202401/01/202301/01/202201/01/202101/01/202001/01/2019
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/202031/12/2019
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date30/09/202515/01/202531/08/202331/08/202230/09/202131/08/2020
General meeting26/09/202518/12/202401/06/202324/08/202201/06/202102/06/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

9 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202426/09/202530/09/2025DutchPDF
Abridged model31/12/202318/12/202415/01/2025DutchPDF
Micro model31/12/202201/06/202331/08/2023DutchPDF
Abridged model31/12/202124/08/202231/08/2022DutchPDF
Abridged model31/12/202001/06/202130/09/2021DutchPDF
Abridged model31/12/201902/06/202031/08/2020DutchPDF
Abridged model31/12/201803/06/201930/08/2019DutchPDF
Abridged model31/12/201701/06/201824/08/2018DutchPDF
Abridged model31/12/201601/06/201705/07/2017DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 2 active · 8 ended

Active mandates

TRAVEL PHARMA

Director · since 31 janvier 2025 · 0644.400.989

Represented by Schmitt ALEXANDER

Active
Marieke Boullart

Director · since 12 décembre 2015

Active

Ended mandates

Alexander Schmitt

Director · since 01 juillet 2018

Ended
Alexander SCHMITT

Manager · since 01 juillet 2018

Ended
Marieke BOULLART

Manager · since 12 décembre 2015

Ended
AUTHORITY

Manager · since 11 décembre 2015 · 0846.644.605

Represented by Alexander SCHIMITT

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates18/11/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates14/05/2025
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates10/09/2018
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates25/01/2016
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other16/12/2015
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 202422,5 k €↑
  2. 2023
    Annual accounts 20231,6 k €↑
  3. 2022
    Annual accounts 2022-8 k €↑
  4. 2021
    Annual accounts 2021-9,2 k €↓
  5. 2019
    Annual accounts 2019831,5 €↓
  6. 2018
    Annual accounts 20183,2 k €↑
  7. 2017
    Annual accounts 2017-14,3 k €↓
  8. 2016
    Annual accounts 2016-3,1 k €
  9. 14/12/2015
    IncorporationPrivate limited company